18-36371033-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001281740.3(FHOD3):​c.273-1647C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.427 in 152,046 control chromosomes in the GnomAD database, including 14,859 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.43 ( 14859 hom., cov: 32)

Consequence

FHOD3
NM_001281740.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.568

Publications

2 publications found
Variant links:
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
  • cardiomyopathy, familial hypertrophic, 28
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.645 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHOD3NM_001281740.3 linkc.273-1647C>T intron_variant Intron 2 of 28 ENST00000590592.6 NP_001268669.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHOD3ENST00000590592.6 linkc.273-1647C>T intron_variant Intron 2 of 28 1 NM_001281740.3 ENSP00000466937.1
FHOD3ENST00000257209.8 linkc.273-1647C>T intron_variant Intron 2 of 24 1 ENSP00000257209.3
FHOD3ENST00000359247.8 linkc.273-1647C>T intron_variant Intron 2 of 23 1 ENSP00000352186.3
FHOD3ENST00000589114.5 linkn.392-1647C>T intron_variant Intron 2 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.427
AC:
64894
AN:
151928
Hom.:
14825
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.558
Gnomad AMI
AF:
0.375
Gnomad AMR
AF:
0.348
Gnomad ASJ
AF:
0.448
Gnomad EAS
AF:
0.664
Gnomad SAS
AF:
0.640
Gnomad FIN
AF:
0.355
Gnomad MID
AF:
0.490
Gnomad NFE
AF:
0.342
Gnomad OTH
AF:
0.435
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.427
AC:
64985
AN:
152046
Hom.:
14859
Cov.:
32
AF XY:
0.430
AC XY:
31931
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.559
AC:
23141
AN:
41432
American (AMR)
AF:
0.348
AC:
5321
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.448
AC:
1553
AN:
3470
East Asian (EAS)
AF:
0.664
AC:
3431
AN:
5170
South Asian (SAS)
AF:
0.639
AC:
3080
AN:
4820
European-Finnish (FIN)
AF:
0.355
AC:
3759
AN:
10578
Middle Eastern (MID)
AF:
0.517
AC:
150
AN:
290
European-Non Finnish (NFE)
AF:
0.342
AC:
23280
AN:
67978
Other (OTH)
AF:
0.440
AC:
929
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1821
3641
5462
7282
9103
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.378
Hom.:
17145
Bravo
AF:
0.426
Asia WGS
AF:
0.650
AC:
2259
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.25
DANN
Benign
0.53
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1893271; hg19: chr18-33950996; API